Model for antibiotic optimization via neoglycosylation: synthesis of liponeoglycopeptides active against VRE
- PMID: 17564440
- DOI: 10.1021/ja068602r
Model for antibiotic optimization via neoglycosylation: synthesis of liponeoglycopeptides active against VRE
Abstract
The neoglycosylation of a methoxyamine-appended vancomycin aglycon with all possible N'-decanoylglucopyranose and N'-biphenoylglucopyranose regioisomers led to the production of a focused set of liponeoglycopeptide variants in good yields and with excellent stereoselectivity. High-throughput antibacterial assays employing a unique set of vancomycin-resistant Enterococci faecalis and Enterococci faecium clinical isolates revealed that the nature and regiochemistry of glycosyl lipidation modulated vancomycin-resistent Enterococci potency. In contrast to prior work with lipoglycopeptides, this study reveals the glucose C3' or C4' as the optimal position for neoglycopeptide lipidation. This purely chemical method for the diversification of the glycolipid portion of lipoglycopeptide antibiotics is simple to perform on a large scale, requires minimal synthetic effort in sugar donor preparation, and provides access to highly active antibiotics that are not easily prepared by other state-of-the-art methods.
Similar articles
-
Antibacterial activity of calozeyloxanthone isolated from Calophyllum species against vancomycin-resistant Enterococci (VRE) and synergism with antibiotics.Planta Med. 2002 Jun;68(6):541-3. doi: 10.1055/s-2002-32558. Planta Med. 2002. PMID: 12094300
-
Characterization of the in vitro activity of novel lipoglycopeptide antibiotics.Curr Protoc Microbiol. 2010 Feb;Chapter 17:Unit17.1. doi: 10.1002/9780471729259.mc1701s16. Curr Protoc Microbiol. 2010. PMID: 20131224
-
Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005.Transplant Proc. 2007 Nov;39(9):2883-5. doi: 10.1016/j.transproceed.2007.08.045. Transplant Proc. 2007. PMID: 18022008
-
Glycopeptides: Update on an old successful antibiotic class.Biochem Pharmacol. 2006 Mar 30;71(7):968-80. doi: 10.1016/j.bcp.2005.12.005. Epub 2006 Jan 18. Biochem Pharmacol. 2006. PMID: 16412985 Review.
-
Origin, structure, and activity in vitro and in vivo of dalbavancin.J Antimicrob Chemother. 2005 Mar;55 Suppl 2:ii15-20. doi: 10.1093/jac/dki005. J Antimicrob Chemother. 2005. PMID: 15750032 Review.
Cited by
-
Natural product disaccharide engineering through tandem glycosyltransferase catalysis reversibility and neoglycosylation.Org Lett. 2012 Oct 5;14(19):5086-9. doi: 10.1021/ol3023374. Epub 2012 Sep 17. Org Lett. 2012. PMID: 22984807 Free PMC article.
-
Enhancing the divergent activities of betulinic acid via neoglycosylation.Org Lett. 2009 Jan 15;11(2):461-4. doi: 10.1021/ol8025704. Org Lett. 2009. PMID: 19102682 Free PMC article.
-
Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics.J Am Chem Soc. 2015 Mar 18;137(10):3693-704. doi: 10.1021/jacs.5b01008. Epub 2015 Mar 9. J Am Chem Soc. 2015. PMID: 25750995 Free PMC article.
-
Enhancement of cyclopamine via conjugation with nonmetabolic sugars.Org Lett. 2012 May 18;14(10):2454-7. doi: 10.1021/ol300703z. Epub 2012 Apr 27. Org Lett. 2012. PMID: 22540932 Free PMC article.
-
Tackling vancomycin-resistant bacteria with 'lipophilic-vancomycin-carbohydrate conjugates'.J Antibiot (Tokyo). 2015 May;68(5):302-12. doi: 10.1038/ja.2014.144. Epub 2014 Oct 29. J Antibiot (Tokyo). 2015. PMID: 25351946
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous